These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16869051)

  • 1. A phase 1 trial disaster: the implications for research.
    Torjesen I
    Circulation; 2006 Jul; 114(3):f110-2. PubMed ID: 16869051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Why has the drug trial at Northwick Park Hospital turned out to a disaster?].
    Lafolie P
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1169-70. PubMed ID: 16696196
    [No Abstract]   [Full Text] [Related]  

  • 3. The elephant in the room.
    Nature; 2006 Dec; 444(7121):790. PubMed ID: 17167433
    [No Abstract]   [Full Text] [Related]  

  • 4. TGN1412: the catalyst for change?
    Altern Lab Anim; 2006 Aug; 34(4):369-71. PubMed ID: 16969950
    [No Abstract]   [Full Text] [Related]  

  • 5. Inquiries in Britain uncover loopholes in drug trials.
    Rosenthal E
    N Y Times Web; 2006 Aug; ():A3. PubMed ID: 16909495
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe incidents in phase I clinical trial. How dangerous is the step from animal to man?].
    Löwer J
    MMW Fortschr Med; 2006 Apr; 148(15):20. PubMed ID: 16711197
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe adverse reactions prompt call for trial design changes.
    Mayor S
    BMJ; 2006 Mar; 332(7543):683. PubMed ID: 16565101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years].
    Glazer A; Hedenmalm K
    Lakartidningen; 2008 Sep 10-16; 105(37):2482-4. PubMed ID: 19006863
    [No Abstract]   [Full Text] [Related]  

  • 9. Opinion: Microdosing: safer clinical trials and fewer animal tests.
    Langley G; Farnaud S
    Bioanalysis; 2010 Mar; 2(3):393-5. PubMed ID: 21083249
    [No Abstract]   [Full Text] [Related]  

  • 10. One drug, six men, disaster..
    Bhattacharya S; Coghlan A
    New Sci; 2006 Mar 25-31; 189(2544):10-1. PubMed ID: 16832959
    [No Abstract]   [Full Text] [Related]  

  • 11. [Principles and practice of clinical phase I studies].
    Hanauske AR
    Onkologie; 2008; 31 Suppl 2():39-45. PubMed ID: 18487868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the TGN1412 trial disaster have lessons for clinical trials in India?
    George T; Srinivasan S
    Natl Med J India; 2006; 19(5):283-6. PubMed ID: 17203685
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethical and design issues of phase I clinical trials in cancer patients.
    Grünwald HW
    Cancer Invest; 2007 Mar; 25(2):124-6. PubMed ID: 17453824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside.
    Sakamoto J; Morita S
    Nagoya J Med Sci; 2007 Jan; 69(1-2):9-16. PubMed ID: 17378175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [After the TGN1412 incident. Principles for assessment of first-in-man trials with monoclonal antibodies by the Paul Ehrlich Institute].
    Schneider CK; Kalinke U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Oct; 50(10):1213-20. PubMed ID: 17924065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A consent form template for phase I oncology trials.
    Koyfman SA; McCabe MS; Emanuel EJ; Grady C
    IRB; 2009; 31(4):1-8. PubMed ID: 19697538
    [No Abstract]   [Full Text] [Related]  

  • 18. UK report recommends better planning for phase I drug trials.
    Mayor S
    BMJ; 2007 Mar; 334(7593):551. PubMed ID: 17363793
    [No Abstract]   [Full Text] [Related]  

  • 19. Urgent changes needed for authorisation of phase I trials.
    Lancet; 2006 Apr; 367(9518):1214. PubMed ID: 16631859
    [No Abstract]   [Full Text] [Related]  

  • 20. 3 + 3 not equal to (Rolling) 6.
    Hartford C; Volchenboum SL; Cohn SL
    J Clin Oncol; 2008 Jan; 26(2):170-1. PubMed ID: 18182656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.